Fernando Civeira Selected Research

Stroke (Strokes)

1/2017	Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
9/2003	Serum chitotriosidase activity is increased in subjects with atherosclerosis disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fernando Civeira Research Topics

Disease

49	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 04/2024 - 04/2002
33	Hypercholesterolemia 04/2024 - 08/2003
26	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 04/2002
21	Atherosclerosis 05/2024 - 09/2003
16	Obesity 02/2024 - 02/2009
16	Dyslipidemias (Dyslipidemia) 12/2023 - 07/2002
12	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2024 - 02/2009
12	Xanthomatosis (Xanthoma) 01/2024 - 03/2004
12	Hypertriglyceridemia 12/2023 - 02/2009
11	Type 2 Diabetes Mellitus (MODY) 02/2024 - 01/2007
10	Hyperlipidemias (Hyperlipidemia) 04/2024 - 06/2002
10	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 01/2018 - 01/2007
9	Arteriosclerosis 04/2024 - 01/2017
9	Hypertension (High Blood Pressure) 12/2022 - 04/2002
9	Insulin Resistance 08/2022 - 11/2009
8	Coronary Disease (Coronary Heart Disease) 11/2023 - 03/2004
7	Inborn Genetic Diseases (Disease, Hereditary) 12/2020 - 03/2004
6	Inflammation (Inflammations) 05/2024 - 06/2002
6	Overweight 04/2021 - 02/2009
5	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2023 - 06/2012
5	Body Weight (Weight, Body) 09/2021 - 08/2014
5	Atherosclerotic Plaque (Atheroma) 01/2020 - 01/2007
4	Injection Site Reaction 01/2019 - 11/2015
4	Homozygous Familial Hypercholesterolemia 01/2019 - 03/2015
4	Pancreatitis 01/2019 - 01/2013
3	Metabolic Diseases (Metabolic Disease) 01/2024 - 01/2018
3	Prediabetic State (Prediabetes) 04/2021 - 01/2020
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2020 - 11/2002
3	Weight Loss (Weight Reduction) 01/2020 - 08/2014
3	Myocardial Infarction 03/2019 - 01/2007
3	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2019 - 01/2018
3	Iron Overload 09/2018 - 02/2010
3	Rare Diseases (Rare Disease) 01/2018 - 01/2016
3	Diabetes Mellitus 01/2015 - 11/2008
3	Carotid Artery Diseases 07/2010 - 11/2009
2	Atrial Fibrillation 01/2023 - 12/2022
2	Myocardial Ischemia (Ischemic Heart Diseases) 12/2022 - 09/2003
2	Hyperlipoproteinemias 08/2021 - 06/2012
2	Stroke (Strokes) 01/2017 - 09/2003
2	Cholestasis 09/2014 - 09/2014

Drug/Important Bio-Agent (IBA)

42	LipidsIBA 01/2024 - 04/2002
34	LDL CholesterolIBA 11/2023 - 11/2002
21	CholesterolIBA 05/2024 - 10/2006
21	Triglycerides (Triacylglycerol)IBA 12/2023 - 11/2008
19	oxidized low density lipoproteinIBA 01/2022 - 04/2002
17	Apolipoproteins E (ApoE)IBA 04/2024 - 11/2007
14	Apolipoproteins B (ApoB)IBA 04/2024 - 10/2005
12	LDL Receptors (LDL Receptor)IBA 01/2024 - 08/2003
12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2021 - 06/2014
11	Lipoproteins (Lipoprotein)IBA 04/2024 - 03/2004
11	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2003
8	ApolipoproteinsIBA 01/2023 - 11/2002
7	Lipoprotein(a)IBA 04/2024 - 07/2014
7	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 02/2009
6	HDL CholesterolIBA 01/2023 - 07/2002
6	SterolsIBA 01/2018 - 08/2014
5	Biomarkers (Surrogate Marker)IBA 05/2024 - 07/2010
5	HDL LipoproteinsIBA 11/2020 - 02/2009
4	Insulin (Novolin)FDA Link 01/2022 - 01/2015
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 09/2013
4	evolocumabIBA 09/2020 - 01/2014
4	Atorvastatin (Lipitor)FDA Link 12/2019 - 06/2002
4	IronIBA 09/2018 - 11/2009
4	Ferritins (Ferritin)IBA 09/2018 - 02/2010
4	Phytosterols (Plant Sterols)IBA 01/2016 - 05/2014
3	Thyroid HormonesIBA 02/2024 - 01/2019
3	Apolipoprotein E2IBA 01/2023 - 01/2008
3	CarbohydratesIBA 04/2021 - 01/2020
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2020 - 01/2015
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2019 - 07/2010
3	PCSK9 InhibitorsIBA 05/2019 - 08/2017
3	NucleotidesIBA 01/2019 - 11/2017
3	Apolipoprotein B-100 (Apo B 100)IBA 01/2019 - 11/2002
3	ProteomeIBA 06/2014 - 11/2009
2	Blood Glucose (Blood Sugar)IBA 09/2023 - 10/2020
2	ORALIT (ORS)IBA 01/2023 - 01/2015
2	27-hydroxycholesterolIBA 01/2022 - 04/2014
2	24-hydroxycholesterolIBA 01/2022 - 04/2014
2	OxysterolsIBA 01/2022 - 04/2014
2	maltodextrinIBA 04/2021 - 01/2020
2	MaltoseIBA 04/2021 - 01/2020
2	isomaltulose (palatinose)IBA 04/2021 - 01/2020
2	DextrinsIBA 04/2021 - 01/2020
2	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 04/2014
2	Antihypertensive Agents (Antihypertensives)IBA 10/2020 - 03/2020
2	CalciumIBA 01/2020 - 03/2016
2	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 11/2019 - 07/2002
2	Proprotein Convertase 9IBA 01/2019 - 12/2016
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2019 - 07/2018
2	MicroRNAs (MicroRNA)IBA 01/2017 - 07/2016
2	alirocumabIBA 01/2016 - 11/2015
2	Ezetimibe (Zetia)FDA Link 01/2016 - 01/2012
2	Phospholipids (Phosphatides)FDA LinkGeneric 09/2013 - 07/2010
2	AntioxidantsIBA 09/2012 - 07/2012
2	Messenger RNA (mRNA)IBA 09/2011 - 11/2007
2	CytokinesIBA 09/2011 - 06/2009

Therapy/Procedure

14	Therapeutics 01/2022 - 06/2014
2	Secondary Prevention 11/2022 - 08/2020
2	Glycemic Control 08/2022 - 01/2020
2	Mediterranean Diet 05/2018 - 11/2017